ArticleOncology letters2026
Primary thymic papillary adenocarcinoma with a rare CD5/CD117-negative and PAX8/WT1-positive immunophenotype: A case report.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary thymic papillary adenocarcinoma (PAT) is an exceptionally rare epithelial malignancy that poses substantial diagnostic challenges due to its non-specific radiological presentation and highly heterogeneous immunophenotype. The present study reports a case of early-stage PAT in a 48-year-old man with a long-standing history of rheumatoid arthritis. Chest computed tomography (CT) revealed a 3.3-cm, well-circumscribed, lobulated anterior mediastinal nodule demonstrating homogeneous contrast enhancement, radiologically mimicking a benign thymic cyst or thymoma. Following complete resection via video-assisted thoracoscopic surgery (VATS), histopathological examination demonstrated a cystic and solid tumor with conspicuous papillary architecture. Diagnostic interpretation was confounded by an atypical immunoprofile: The tumor was negative for the traditional thymic carcinoma markers CD5 and CD117, yet exhibited diffuse expression of paired box gene 8 and WT1, thereby closely resembling metastatic renal cell carcinoma or mesothelioma. A diagnosis was strongly supported through a rigorous process of exclusion, integrating an extended negative immunohistochemical panel (including Spalt-like transcription factor 4, thyroid transcription factor-1 and D2-40) with the morphological identification of residual atrophic thymic tissue at the tumor periphery. The tumor was classified as Masaoka-Koga stage I PAT, and the patient remained free of recurrence at the 6-month postoperative follow-up. The present case highlights the diagnostic pitfalls of PAT, particularly its deceptively benign imaging appearance and unusual immunophenotype. It emphasizes that CD5/CD117 negativity does not preclude a thymic origin, underscoring the necessity of a comprehensive, exclusion-based approach for accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.